Høydosebehandling med autolog stamcellestøtte ved lymfom – fra utprøvende til standard behandling
- 2.
Swerdlow SH, Campo E, Harris NL et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. 4. utg. Lyon: IARC, 2008.
- 3.
Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne lymfomer nr. 987-82-8081-113-4/2012. Oslo: Norsk lymfomgruppe, 2012.
- 4.
Cancer in Norway 2010 – cancer incidence, mortality, survival and prevalence in Norway 2012. Oslo: Kreftregisteret, 2012.
- 7.
Osgood EE, Riddle MC, Matthews TJ. Aplastic anemia treated with daily transfusions and intravenous marrow. Case report. Ann Intern Med 1939; 13: 357 – 67. [CrossRef]
- 8.
Lorenz E, Uphoff D, Reid TR et al. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951; 12: 197 – 201. [PubMed]
- 10.
Appelbaum FR, Herzig GP, Ziegler JL et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85 – 95. [PubMed]
- 11.
Bone-marrow autotransplantation in man. Report of an international cooperative study. Lancet 1986; 2: 960 – 2. [PubMed]
- 14.
Sweetenham JW, Santini G, Qian W et al. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001; 19: 2927 – 36. [PubMed]
- 22.
Geisler CH, Kolstad A, Laurell A et al. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 2008; 112: 2687 – 93. [PubMed] [CrossRef]
- 23.
Høydosebehandling med autolog stamcellestøtte ved maligne lidelser. Helsedirektoratets utredningsserie 1 – 951995. Oslo: Statens helsetilsyn, 1995.
- 26.
Hoppe RT, Advani RH, Ai WZ et al. Hodgkin lymphoma Version 2.2013. National Comprehensive Cancer Network Clinical Practice Guidelines. www.jnccn.org/content/10/5/589.short (25.4.2013).
- 27.
Zelenetz AD, Abramson JS, Advani RH et al. Non-Hodgkin's lymphomas Version 1.2013. National Comprehensive Cancer Network Clinical Practice Guidelines. www.jnccn.org/content/11/3/257.abstract (25.4.2013).
- 28.
Bosly A, Coiffier B, Gisselbrecht C et al. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J Clin Oncol 1992; 10: 1615 – 23. [PubMed]
- 33.
Dreyling M, Lenz G, Hoster E et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005; 105: 2677 – 84. [PubMed] [CrossRef]
- 34.
Schaaf M, Reiser M, Borchmann P et al. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Cochrane Database Syst Rev 2012; 1: CD007678.